18 Years
N/A
Both
Basal Cell Carcinoma
Trial Information
Background and Aim:
Basal cell carcinoma (BCC) is the most common skin cancer .Photodynamic therapy _as a novel
, non-invasive therapeutic approach _may be considered a valuable strategy. This study was
designed with the aim of the evaluation of efficacy of PDT in treatment of BCC and
recurrence rate after 6 months .
Materials and Methods:
This was a clinical trial which was done on 28 BCCs. Patients were treated with ALA-PDT
monthly for 1-6 sessions and evaluated for clinical response,cosmetic results,recurrence
rate and probable side effects.
Inclusion Criteria:
- Histologically proven BCCs
Exclusion Criteria:
- Rodent ulcer
- Morphea type
- ANA +
- History of photosensitivity or photodermatosis or ingestion of phototoxic drugs
during last month
- Pregnancy
- Breast feeding
- Age< 18
- History of another therapeutic intervention for bcc during last 6 months
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
response rate at the end of therapy protocol (regarding tumor diameter and/or pathologic examination)
Outcome Time Frame:
1 year
Safety Issue:
Yes
Principal Investigator
zohreh Tehranchi-nia, assist.prof.
Investigator Role:
Principal Investigator
Investigator Affiliation:
skin research center
Authority:
Iran: Ethics Committee
Study ID:
pdt bcc 2
NCT ID:
NCT00988455
Start Date:
January 2008
Completion Date:
August 2009
Related Keywords:
- Basal Cell Carcinoma
- basal cell carcinoma
- photodynamic therapy
- photo chemotherapy
- basal cell epithelioma
- Carcinoma
- Carcinoma, Basal Cell
Name | Location |
|---|
